These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4684940)

  • 1. [The effect of spironolactone and thiabutazide on serum-uric acid and lipid levels in patients with gout and in healthy persons].
    Mertz DP
    Dtsch Med Wochenschr; 1973 Jan; 98(1):11-5. PubMed ID: 4684940
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of allopurinol (Zyloric) on uric acid, creatinine, fasting blood sugar and plasma lipids in patients with gout].
    Günther R; Knapp E
    Wien Klin Wochenschr; 1970 Jan; 82(5):78-82. PubMed ID: 5513199
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of the effect of hypouricaemic therapy on serum lipid levels in gout patients.
    Darlington LG; Scott JT
    Adv Exp Med Biol; 1986; 195 Pt A():341-4. PubMed ID: 3728165
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of allopurinol on plasma lipid fractions in gout patients].
    Giovannelli G; Carcassi A; Gragnoli G; Marcolongo R; Pupillo A
    Atti Accad Fisiocrit Siena Med Fis; 1967; 16(2):1011-24. PubMed ID: 5621168
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gout and plasma lipid values].
    Günther R; Knapp E; Siller K
    Wien Klin Wochenschr; 1968 Jul; 80(29):577-81. PubMed ID: 5705694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipid disorders in gout and in hyperuricemia with myalgia].
    Roux H; Vovan L; Dutertre P; Serratrice G; Recordier AM
    Mars Med; 1972; 109(10):609-25. PubMed ID: 4659841
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the influence of Anturan on ric acid and plasma lipids in patients with gout].
    Günther R; Herbst M; Knapp E; Siller K
    Wien Klin Wochenschr; 1968 Jun; 80(24):473-8. PubMed ID: 5692866
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of triglyceridemia, lipemia, glycemia and weight index in patients with high and normal serum uric acid].
    Kuntz D; Rouques C; Paolaggi F; Ryckewaert A
    Pathol Biol (Paris); 1969 Apr; 17(7):399-403. PubMed ID: 4893908
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid disorders in gout and hyperuricemias].
    Roux H; Vovan L; Dutertre P; Serratrice G; Recordier AM
    Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):95-105. PubMed ID: 4705340
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
    Matzkies F
    Med Klin (Munich); 1992 Sep; 87(9):460-2. PubMed ID: 1406482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results obtained with long-term benzbromarone therapy (author's transl)].
    Bresnik W; Müller MM
    Wien Klin Wochenschr; 1974 May; 86(10):283-7. PubMed ID: 4428763
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 16. [The relationship of uric acid, triglycerides, and cholesterol].
    Krupar V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1978; 21(4):361-99. PubMed ID: 316921
    [No Abstract]   [Full Text] [Related]  

  • 17. Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout?
    Perez-Ruiz F; Lioté F
    Arthritis Rheum; 2007 Oct; 57(7):1324-8. PubMed ID: 17907217
    [No Abstract]   [Full Text] [Related]  

  • 18. Avascular necrosis and its relation to lipid and purine metabolism.
    Mielants H; Veys EM; DeBussere A; van der Jeught J
    J Rheumatol; 1975 Dec; 2(4):430-6. PubMed ID: 1206674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alterations of lipid metabolism in primary gout and hyperuircemia].
    Mertz DP; Zaar I; Klöpfer-Zaar M; Henninges D; Thieme G; Scheier CA
    Dtsch Med Wochenschr; 1971 Mar; 96(12):488-93. PubMed ID: 5548321
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.